|
|
HL7 - Version 2.7.1 |
|
|
| Interpretation: | nicht verwendet |
| OID Table: | 2.16.840.1.113883.12.330 |
| Codesystem OID: | 2.16.840.1.113883.18.201 Version 1 |
| Value Set OID: | 2.16.840.1.113883.21.213 |
| Binding: | universal |
| Expansion: | all codes from codesystem |
| Vocabulary Domain: | tbd |
| Table Type: | HL7 |
| Case insensitive: | Falsch |
| Steward: | OO |
| Status: | Active |
| Section | 2.C.2.161 |
| Value | Description | German Interpretation | Comment | Chapter |
|---|---|---|---|---|
| 510K | 510 (K) | 2.C.2.161 | ||
| 510E | 510 (K) exempt | 2.C.2.161 | ||
| PMA | Premarketing authorization | 2.C.2.161 | ||
| PRE | Preamendment | 2.C.2.161 | ||
| TXN | Transitional | 2.C.2.161 | ||
| 522S | Post marketing study (522) | 2.C.2.161 |
| Links to Other/Further HL7 Information | generated: Jun 13, 2024 (FO) | |||
| Health Level Seven, Int. (HQ) |
HL7 Germany HL7 Europe |
Frank Oemig's HL7 Site (Infos about the database) |
HL7-Experts Network | |